GSK Abreva Ad Claims Lack Supporting Data – Lawsuit
This article was originally published in The Tan Sheet
Executive Summary
Data from studies measuring the efficacy of GlaxoSmithKline's OTC cold sore treatment Abreva do not substantiate ad claims for the product, Merix Pharmaceutical alleges in a false advertising suit